EUVIMEDEUVIMED entdecken
Crossref

Safety of Dexmedetomidine Use in Adult ICU Patients With Right Ventricular Dysfunction

Amoreena Most iD, Nicholas Farina iD, James T Miller, Matthew C Konerman, Sarah Adie iD

Journal of Pharmacy Practice · 04.11.2026

DOI: 10.1177/08971900261506735 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy Practice, online erschienen am 04.11.2026. Verfasst von Amoreena Most und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Michigan Health, Ann Arbor, MI, USA. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dexmedetomidine is commonly used in the intensive care unit (ICU) and is associated with hemodynamic adverse events, including hypotension and bradycardia. Use of dexmedetomidine has not been described in critically ill patients with right ventricular (RV) dysfunction and may be particularly relevant given the tenuous hemodynamics in this patient population.

Objective

Determine the prevalence of adverse events in adult ICU patients with RV dysfunction receiving dexmedetomidine.

Methods

This single-center, retrospective cohort study included adult ICU patients with RV dysfunction measured by echocardiogram who received dexmedetomidine between January 2017 and December 2022. The primary outcome was a composite of adverse events after dexmedetomidine initiation including bradycardia, hypotension, increasing vasopressor/inotrope requirements, and asystole. Secondary outcomes included individual components of the primary outcome and a comparison of adverse events based on RV dysfunction severity.

Results

A total of 245 patients met study inclusion criteria. A total of 178 adverse events occurred in 153 patients (62.4%). The most common adverse event was hypotension occurring in 129 patients (72.5%). Increased vasopressor requirements occurred in 35 patients (19.7%), and mean change in norepinephrine equivalents from baseline was 0.06 µg/kg/min. Adverse event rates did not differ among patients with mild, moderate, or severe RV dysfunction.

Conclusion

Adult ICU patients with RV dysfunction receiving dexmedetomidine experienced high rates of hypotension and increased vasopressor requirements. Findings from this study may assist in tailoring sedation regimens for critically ill patients with RV dysfunction. Future research is needed to explore optimal sedative agents in this patient population.

Schlagwörter

Stichwörter der Autor:innen

dexmedetomidinehemodynamicsright ventricular dysfunction

Autor:innen und Institutionen

  • Department of Pharmacy, University of Michigan Health, Ann Arbor, MI, USA.
  • Department of Pharmacy, Intermountain Medical Center, Murray, UT, USA.
  • Division of Cardiology, Department of Medicine, University of Michigan Health, Ann Arbor, MI, USA.

ORCID-Profile: Amoreena Most, Nicholas Farina, Sarah Adie

Zitieren

APA

Most, A., Farina, N., Miller, J. T., Konerman, M. C., & Adie, S. (2026). Safety of Dexmedetomidine Use in Adult ICU Patients With Right Ventricular Dysfunction. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900261506735

Vancouver

Most A, Farina N, Miller JT, Konerman MC, Adie S. Safety of Dexmedetomidine Use in Adult ICU Patients With Right Ventricular Dysfunction. Journal of Pharmacy Practice. 2026. doi:10.1177/08971900261506735

BibTeX
@article{Most2026,
  author = {Most, Amoreena and Farina, Nicholas and Miller, James T and Konerman, Matthew C and Adie, Sarah},
  title = {Safety of Dexmedetomidine Use in Adult ICU Patients With Right Ventricular Dysfunction},
  journal = {Journal of Pharmacy Practice},
  year = {2026},
  doi = {10.1177/08971900261506735}
}
Kostenlos starten →